Sialylated IgE Detection Using Lectin Capture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting sialylation of IgE are laborious, requiring large volumes of blood, complex purification processes, and skilled labor, making them unsuitable for clinical settings, and there is a lack of reliable in vitro methods for diagnosing allergy based on sialylation patterns.
Innovation Solution
A method using a capture probe specific for sialylated glycoproteins, such as SNA-1 lectin, to immobilize sialylated IgE, followed by an antibody-based detection technique, like a colorimetric assay with horseradish peroxidase, for quantifying sialylated IgE in a simple and interpretable manner.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods for detecting sialylation of IgE are used, then sialylated IgE can be detected, but the process becomes laborious and complex
Solution Approach 1:
The patent introduces SNA-1 lectin as an intermediary substance that specifically binds to sialylated IgE. This lectin acts as a mediator between the sample and the detection system, enabling selective capture of sialylated IgE without complex purification. The lectin forms a stable complex with sialylated IgE that can be easily separated and detected, resolving the contradiction between detection precision and process complexity.
2Measurement precision
If current methods for detecting sialylation of IgE are used, then sialylated IgE can be detected, but large volumes of blood are required
Solution Approach 1:
The patent extracts and isolates only the sialylated IgE fraction from the complex serum matrix using SNA-1 lectin binding. By taking out specifically the sialylated portion through lectin-affinity capture, the method achieves high detection precision with minimal sample volume, eliminating the need for large blood volumes required by conventional methods.
3Measurement precision
If current methods for detecting sialylation of IgE are used, then sialylated IgE can be detected, but skilled labor is required
Solution Approach 1:
The SNA-1 lectin performs self-service by automatically and specifically binding to sialylated IgE in the sample without requiring skilled manual intervention. The lectin's inherent specificity for sialylated glycans enables automated capture and detection, making the procedure accessible to routine laboratory personnel while maintaining high detection precision.
4Measurement precision
If in vitro tests for slgE are performed, then circulating slgE antibodies can be detected, but the results do not correlate with symptom severity
Solution Approach 1:
The patent applies local quality by focusing detection on the specific sialylated form of IgE rather than total IgE or unsialylated forms. This localized detection of sialylated IgE provides clinically relevant information that correlates with allergic symptom severity, recovering the lost diagnostic information while maintaining antibody detection capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a reliable, minimally invasive technique for quantifying sialylated IgE, distinguishing allergic from non-allergic subjects, with high sensitivity and specificity, enabling accurate allergy diagnosis and treatment.
Implementation Method 1
A technique developed by Wu et al. for quantifying the sialylation of the IgG family of immunoglobulins requires minimal sample processing and provides a spectroscopic readout. This method utilises the interaction between sialic acid and SNA-1 lectin to specifically immobilise sialylated IgG from sera.
Implementation Method 2
IgE-specific horseradish peroxidase (HRP) conjugate antibodies were then used to colorimetrically detect the bound, sialylated IgE through the activity of HRP
Implementation Method 3
IgE-specific horseradish peroxidase (HRP) conjugate antibodies were then used to colorimetrically detect the bound, sialylated IgE through the activity of HRP
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
The invention relates to a method of quantifying sialylated IgE in a test sample, the method comprising: immobilising sialylated IgE in the test sample via a capture probe which is specific for sialylated glycoproteins, wherein the capture probe is immobilised; and using an antibody-based detection technique to quantify sialylated IgE. The invention further relates to: diagnosis of allergy in a subject, methods of treatment comprising diagnosis of allergy followed by treatment by immunotherapy, kits comprising reagents for the method, and use of the kits to quantify sialylated IgE in a test sample.